{
  "id": 19613698,
  "title": "While banks fear volatility, CME Group surged 15%: Is it a buy?",
  "url": "https://urgent.news/2026/11/12/while-banks-fear-volatility-cme-group-surged-15-is-it-a-buy",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-12T06:41:26.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/while-banks-fear-volatility-cme-group-surged-15-is-it-a-buy-5018813"
  },
  "original_language": "en",
  "account": "Recent market volatility has caused traditional banks to struggle, but CME Group has thrived alongside. The world's largest derivatives marketplace saw its stock rise 15% since early October, trading near $307.20 and decoupling from the banking sector's turmoil. The broad financial division is divided: banks face challenges in underwriting and corporate deals, while CME converts liquidity shifts into high-margin transaction fees. As capital moves from deposit-sensitive lenders to asset-light infrastructure, CME's operating moat lies in its regulatory scale and liquidity monopoly across global benchmark derivatives. The Chicago Mercantile Exchange, CBOT, NYMEX, and COMEX give CME a virtual monopoly, allowing it to charge transaction fees without facing default exposure like traditional financial institutions. In Q3, CME's revenue grew 13% year-over-year to $1.74 billion, with average daily volume hitting an all-time high of 29.4 million contracts, a 16% increase year-over-year. High-margin market data revenue also climbed 20% to $243 million, marking 34 consecutive quarters of expansion. CME's 69.4% adjusted operating margin converted over 55% of its total revenue into free cash flow, funding nearly $1 billion in shareholder returns. Despite cautious consensus targets, CME's valuation presents a valuation disconnect, trading at a modest 24.7 times forward earnings compared to the above-35 times earnings typically commanded by comparable enterprise software firms. Analysts project EPS growth to reach $14.23 by 2028. Momentum in fourth quarter suggests trading volumes are currently 17% above last year's record pace. This growth highlights why market infrastructure provides a more durable foundation during macro uncertainty than traditional commercial banking. InvestingPro's strategies can help investors identify companies turning market activity into verified cash flow, with full access costing just $9 a month. No position held in the mentioned stocks.",
  "summary": null,
  "key_points": [
    "CME Group's stock surged 15% since early October, trading near $307.20.",
    "CME's 69.4% adjusted operating margin converted over 55% of its total revenue into free cash flow."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}